Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;11(7.1):10.18103/mra.v11i7.1.4064.
doi: 10.18103/mra.v11i7.1.4064. Epub 2023 Jul 6.

Antigen Presenting Cell-Mediated HIV-1 Trans Infection in the Establishment and Maintenance of the Viral Reservoir

Affiliations

Antigen Presenting Cell-Mediated HIV-1 Trans Infection in the Establishment and Maintenance of the Viral Reservoir

Abigail Gerberick et al. Med Res Arch. 2023 Jul.

Abstract

Despite potent antiretroviral therapy, an HIV-1 reservoir persists that represents a major barrier to a cure. Understanding the mechanisms by which the HIV-1 reservoir is established and maintained is critical for the discovery of effective treatments to significantly reduce or eliminate the viral reservoir. In addition to cis infection, in which HIV-1 directly infects target CD4+ T cells, cell-to-cell transmission, or trans infection, can also occur. HIV-1 trans infection is significantly more efficient than cis infection, mostly due to the occurrence of multiple infections per cell during transfer. Additionally, trans infection is efficient even in the presence of ART and/or neutralizing antibodies. Cell-to-cell transmission is mediated by CD4+ T cells and professional antigen presenting cells (APC). Here we focus on APC, i.e., myeloid dendritic cells, B lymphocytes, and monocytes/macrophages, that bind, internalize, and transfer HIV-1 to target CD4+ T cells via various proposed mechanisms. We assess the potential impact of trans infection on the establishment and maintenance of the HIV-1 reservoir including its role in disease progression. We consider the natural interactions between APC and CD4+ T cells in vivo that HIV-1 may hijack, allowing for the highly efficient trans infection of CD4+ T cells, maintaining the viral reservoirs in tissue despite undetectable plasma viral loads in peripheral blood. We propose that these modes of viral pathogenesis need to be addressed in potential cure strategies to ensure eradication of the viral reservoir.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors have no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Schematic depicting APC and CD4+ T cells interactions with proposed HIV-1 trans infections. (A) At the site of infection in sexually transmitted cases, macrophages (Mφ) and iDC bind HIV-1 via DC-SIGN or DC-SIGN and Siglec-1, respectively, which they transfer to target CD4+ T cells. (B) Lymph node areas defined. CCL19/21 chemokine gradient guides DC to paracortex (T cell zone). (C) Subcapsular macrophages (SCM) in the SCS bind HIV-1 via Siglec-1 and trans infect CD4+ T cells in the paracortex. (D) Naïve B cells (BN) survey SCM for their cognate antigen and bind HIV-1 presented on SCM via DC-SIGN. Once activated, B cells upregulate CCR7 and travel to the B:T cell border by the CCL19/21 chemokine gradient. At the B:T cell border, B cells survey CD4+ T cells. B cells may transfer virus to TN cells while surveying or to pre-TFH cells during their antigen-specific interaction. B cells and now fully differentiated TFH cells can subsequently form GC where further B cell-mediated trans infections occur. (E) In the paracortex, mDC that have internalized HIV-1 survey CD4+ T cells for their cognate TN cell and transfer virus during these interactions. iDC that migrate into SLO bind HIV-1 via DC-SIGN and trans infect CD4+ T cells. Figure created with BioRender.com.

Similar articles

References

    1. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med Aug 2009;15(8):893–900. doi:10.1038/nm.1972 - DOI - PMC - PubMed
    1. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med May 1999;5(5):512–7. doi:10.1038/8394 - DOI - PubMed
    1. Eisele E, Siliciano RF. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity Sep 21 2012;37(3):377–88. doi:10.1016/j.immuni.2012.08.010 - DOI - PMC - PubMed
    1. Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A Nov 25 1997;94(24):13193–7. doi:10.1073/pnas.94.24.13193 - DOI - PMC - PubMed
    1. Smith MZ, Wightman F, Lewin SR. HIV reservoirs and strategies for eradication. Curr HIV/AIDS Rep Mar 2012;9(1):5–15. doi:10.1007/s11904-011-0108-2 - DOI - PubMed

LinkOut - more resources